| 000 | 01883 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516153146.0 | ||
| 264 | 0 | _c20140128 | |
| 008 | 201401s 0 0 eng d | ||
| 022 | _a1760-4788 | ||
| 024 | 7 |
_a10.1007/s12603-013-0335-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPapanicolaou, D A | |
| 245 | 0 | 0 |
_aA phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia. _h[electronic resource] |
| 260 |
_bThe journal of nutrition, health & aging _c2013 |
||
| 300 |
_a533-43 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAbsorptiometry, Photon |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAzasteroids _xadministration & dosage |
| 650 | 0 | 4 |
_aBody Composition _xdrug effects |
| 650 | 0 | 4 |
_aDietary Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aDietary Supplements |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFrail Elderly |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMuscle Strength _xdrug effects |
| 650 | 0 | 4 |
_aMuscle, Skeletal _xdrug effects |
| 650 | 0 | 4 |
_aMusculoskeletal Physiological Phenomena _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Androgen _xdrug effects |
| 650 | 0 | 4 |
_aSarcopenia _xdrug therapy |
| 650 | 0 | 4 |
_aVitamin D _xadministration & dosage |
| 700 | 1 | _aAther, S N | |
| 700 | 1 | _aZhu, H | |
| 700 | 1 | _aZhou, Y | |
| 700 | 1 | _aLutkiewicz, J | |
| 700 | 1 | _aScott, B B | |
| 700 | 1 | _aChandler, J | |
| 773 | 0 |
_tThe journal of nutrition, health & aging _gvol. 17 _gno. 6 _gp. 533-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12603-013-0335-x _zAvailable from publisher's website |
| 999 |
_c22804280 _d22804280 |
||